Combining JAK2 and LSD1 inhibitors in SETBP1 mutant CNL. (A) JAK2 inhibitors are relatively effective only in the rare CNL cases with isolated CSF3R mutations. (B) Combining JAK2 inhibitors with LSD1 inhibitors may be effective in SEPBP1 mutant CNL.